glp-1 precio costs rise, but there are ways to save on weight-loss drugs Discounts on GLP-1 Medications from
Description
Ending coverage for GLP-1 obesity drugs would be in line with current financial trends in both public and private insurance companies but could result in health inequities and less comprehensive coverage for a large segment of Rhode Islands population, the budget note reads
While GLP-1 RA prevalence among non-diabetic adults held steady at 0.1% from 2018-2021, it quadrupled to 0.4% in 2022 alone
2019;8(12):e012356
It would be fair to expect that GLP-1s, given they fall into both categories, will be a focus
